Keyphrases
Wound Inflammation
100%
Wound Infection
100%
TCP-25
100%
Polyurethane Materials
100%
Inflammation
42%
Porcine
28%
Bacterial Infection
28%
Staphylococcus Aureus
28%
Endotoxin
28%
Anti-infective
28%
Polyurethane
28%
Anti-inflammatory Effect
28%
Toll-like
28%
Need for Treatment
14%
Interleukin-6
14%
Inflammatory Response
14%
Difficult-to-treat
14%
Thrombin
14%
Receptor Agonist
14%
Surgical Site Infection
14%
Mouse Model
14%
Antimicrobial Resistance
14%
Antibiotics
14%
Inflammatory Cells
14%
Pig Model
14%
Pseudomonas Aeruginosa (P. aeruginosa)
14%
Infection-related
14%
Infection Prevention
14%
NF-B
14%
Minipig
14%
In Vivo Model
14%
Systemic Complications
14%
Reduced Activation
14%
Dimerization
14%
Wound Dressing
14%
Cellular Assay
14%
Wound Pathogens
14%
THP1
14%
Wound Infection Model
14%
Antiseptic
14%
Dual Action
14%
Excessive Inflammatory Response
14%
Microbiological Assay
14%
Wound Model
14%
In Vivo Assay
14%
Lipoteichoic Acid
14%
Biophysical Assays
14%
Host Defense Peptides
14%
Partial-thickness Wound
14%
Implant Model
14%
Reporter Cells
14%
Local Wound Infection
14%
Antibacterial Coating
14%
Biomaterial-associated Infection
14%
Helical Conformation
14%
Subcutaneous Implantation
14%
Combined Antibacterial
14%
Localized Infection
14%
Antibacterial Peptide
14%
Pharmacology, Toxicology and Pharmaceutical Science
Inflammation
100%
Wound Infection
100%
Polyurethan
100%
Infection
83%
Antiinfective Agent
50%
Mouse
33%
Pig
33%
Bacterial Infection
33%
Staphylococcus Aureus
33%
Antiinflammatory Activity
33%
Endotoxin
33%
Tumor Necrosis Factor
16%
Infectious Agent
16%
Thrombin
16%
Surgical Infection
16%
Antimicrobial Resistance
16%
Porcine Model
16%
Wound
16%
Pseudomonas aeruginosa
16%
Antibiotic Agent
16%
Mouse Model
16%
Polypeptide Antibiotic Agent
16%
Implant
16%
Toll Like Receptor Agonist
16%
Experimental Surgical Wound
16%
Wound Dressings
16%
Toll Like Receptor 4
16%
Minipig
16%
Biomaterial
16%
Lipoteichoic Acid
16%
Medicine and Dentistry
Wound Infection
100%
Polyurethan
100%
Infection
66%
In Vitro
66%
Antiinfective Agent
50%
Serositis
33%
Bacterial Infection
33%
Antiinflammatory Activity
33%
Staphylococcus Aureus
33%
Endotoxin
33%
Tumor Necrosis Factor
16%
Interleukin-6
16%
Pathogen
16%
Thrombin
16%
Surgical Infection
16%
Implant
16%
Inflammatory Cell
16%
Wound
16%
Antibiotics
16%
Pseudomonas aeruginosa
16%
Host Resistance
16%
Toll Like Receptor Agonist
16%
Biocompatible Material
16%
Antibiotic Resistance
16%
Wound Dressings
16%
Toll Like Receptor 4
16%
Infection Prevention
16%
Experimental Surgical Wound
16%
Polypeptide Antibiotic Agent
16%
Lipoteichoic Acid
16%